Chief Science Officer
Josh has extensive research and entrepreneurial experience in the biotech and pharmaceutical development space. His keen interest in human health and the development of plant-based therapeutics further enhances his role at Tilray where he leads the company’s team of experts including PhD research scientists, botanists and horticulturalists, all industry leaders in their fields on the cutting edge of advancing the science, safety and efficacy of medical cannabis for patients and physicians.
Senior Technology Officer at The University of British Columbia
Josh was active in the transformation and translation of university and hospital research into the private sector. Over nearly 10 years as an academic business development professional, Josh helped establish and incubate numerous university spin-off companies, and worked with local, national, and international companies and research organizations to develop key health-related research partnerships, including preclinical and clinical study development.
University of British Columbia: BS
University of Victoria: PhD, Biology